Cat. No.: X23-10-ZQ360
JAK inhibitor BD750, Purity ≥98%
Synonym: bd750; 892686-59-8; 2-(1,3-Benzothiazol-2-yl)-4,5,6,7-tetrahydro-2H-indazol-3-ol; 895845-12-2; 2-(Benzo[d]thiazol-2-yl)-4,5,6,7-tetrahydro-2H-indazol-3-ol; JAK inhibitor
- CAS Number: 892686-59-8
- Compound CID: 16459674
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Properties
Description
BD750 is an available JAK small molecule inhibitor with potential antineoplastic activity.
Molecular Formula
C14H13N3OS
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
BD750 is employed in research to investigate its role and effectiveness as a JAK7 inhibitor in cancer and neurological disease models.
Related Products
- JAK inhibitor JAK/HDAC-IN-1, Purity ≥98%
- JAK inhibitor 1,2,3,4,5,6-Hexabromocyclohexane, Purity ≥98%
- JAK inhibitor Abrocitinib, Purity ≥98%
- JAK inhibitor AZ-3, Purity ≥98%
- JAK inhibitor AZ-960, Purity ≥98%
- JAK inhibitor AZD1480, Purity ≥98%
